MetLife (MET) analyst forecast and price target
Analyst forecast
Consensus of 22 analyst ratings
Based on 11 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Morgan Stanley | Maintained | Overweight | $111.00 from $103.00 | Aug 24, 2026 |
| Wells Fargo | Maintained | Overweight | $109.00 from $101.00 | Aug 19, 2026 |
| Keefe, Bruyette & Woods | Maintained | Outperform | $108.00 from $105.00 | Aug 11, 2026 |
| JP Morgan | Maintained | Overweight | $108.00 from $106.00 | Aug 11, 2026 |
| Barclays | Maintained | Overweight | $97.00 from $94.00 | Aug 6, 2026 |
| TD Cowen | Maintained | Buy | $105.00 from $87.00 | Jul 22, 2026 |
| JP Morgan | Maintained | Overweight | $106.00 from $96.00 | Jul 21, 2026 |
| Keefe, Bruyette & Woods | Maintained | Outperform | $105.00 from $98.00 | Jul 13, 2026 |
| Evercore ISI Group | Maintained | In-Line | $103.00 from $96.00 | Jul 13, 2026 |
| Jefferies | Maintained | Buy | $103.00 from $97.00 | Jul 10, 2026 |
| Mizuho | Maintained | Outperform | $102.00 from $95.00 | Jul 9, 2026 |
| Wells Fargo | Maintained | Overweight | $101.00 from $95.00 | Jul 9, 2026 |
| UBS | Maintained | Buy | $105.00 from $102.00 | Jul 8, 2026 |
| Barclays | Maintained | Overweight | $94.00 from $93.00 | Jul 7, 2026 |
| Morgan Stanley | Maintained | Overweight | $103.00 from $93.00 | Jul 6, 2026 |
| Piper Sandler | Maintained | Neutral | $90.00 from $86.00 | Jun 24, 2026 |
| Piper Sandler | Maintained | Neutral | $86.00 from $81.00 | May 26, 2026 |
| Morgan Stanley | Maintained | Overweight | $93.00 from $89.00 | May 21, 2026 |
| Keefe, Bruyette & Woods | Maintained | Outperform | $98.00 from $87.00 | May 13, 2026 |
| Wells Fargo | Maintained | Overweight | $95.00 from $90.00 | May 12, 2026 |
Frequently asked questions
What is the price target for MET stock?
The average 12-month analyst price target for MetLife (MET) is $103.73, with a high estimate of $111.00 and a low of $90.00, across 11 analysts.
Is MET a buy, sell, or hold?
Analysts covering MetLife currently average a Buy rating: 14 buy, 6 hold and 2 sell, from 22 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for MET?
The average price target of $103.73 implies 8.65% upside from the last price of $95.47.
What is the latest analyst rating on MET?
On Aug 24, 2026, Morgan Stanley maintained MetLife at Overweight with a price target of $111.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.